• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIF1A-AS2 通过 miR-141-3p/FOXC1 轴促进结直肠癌细胞的代谢重编程和进展。

HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis.

机构信息

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.

出版信息

Cell Death Dis. 2024 Sep 3;15(9):645. doi: 10.1038/s41419-024-06958-2.

DOI:10.1038/s41419-024-06958-2
PMID:39227375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372083/
Abstract

lncRNA can regulate tumorigenesis development and distant metastasis of colorectal cancer (CRC). However, the detailed molecular mechanisms are still largely unknown. Using RNA-sequencing data, RT-qPCR, and FISH assay, we found that HIF1A-AS2 was upregulated in CRC tissues and associated with poor prognosis. Functional experiments were performed to determine the roles of HIF1A-AS2 in tumor progression and we found that HIF1A-AS2 can promote the proliferation, metastasis, and aerobic glycolysis of CRC cells. Mechanistically, HIF1A-AS2 can promote FOXC1 expression by sponging miR-141-3p. SP1 can transcriptionally activate HIF1A-AS2. Further, HIF1A-AS2 can be packaged into exosomes and promote the malignant phenotype of recipient tumor cells. Taken together, we discovered that SP1-induced HIF1A-AS2 can promote the metabolic reprogramming and progression of CRC via miR-141-3p/FOXC1 axis. HIF1A-AS2 is a promising diagnostic marker and treatment target in CRC.

摘要

长链非编码 RNA(lncRNA)可调节结直肠癌(CRC)的发生发展和远处转移。然而,其详细的分子机制在很大程度上尚不清楚。本研究通过 RNA 测序数据、RT-qPCR 和 FISH 检测发现,HIF1A-AS2 在 CRC 组织中上调,并与不良预后相关。功能实验确定了 HIF1A-AS2 在肿瘤进展中的作用,结果表明 HIF1A-AS2 可促进 CRC 细胞的增殖、转移和有氧糖酵解。机制上,HIF1A-AS2 通过海绵吸附 miR-141-3p 促进 FOXC1 的表达。SP1 可转录激活 HIF1A-AS2。此外,HIF1A-AS2 可被包装到外泌体中,并促进受体肿瘤细胞的恶性表型。综上所述,本研究发现,SP1 诱导的 HIF1A-AS2 通过 miR-141-3p/FOXC1 轴促进 CRC 的代谢重编程和进展。HIF1A-AS2 是 CRC 有前途的诊断标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/d76444e9aa40/41419_2024_6958_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/0e8a8bc1851c/41419_2024_6958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/82789c8beed1/41419_2024_6958_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/902a1435c15a/41419_2024_6958_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/59c87dca2d69/41419_2024_6958_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/b3a2ad415e3e/41419_2024_6958_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/fc17548efd52/41419_2024_6958_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/e9a011c80fac/41419_2024_6958_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/f7f5dda4b1c0/41419_2024_6958_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/bfb8a52c2293/41419_2024_6958_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/d76444e9aa40/41419_2024_6958_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/0e8a8bc1851c/41419_2024_6958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/82789c8beed1/41419_2024_6958_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/902a1435c15a/41419_2024_6958_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/59c87dca2d69/41419_2024_6958_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/b3a2ad415e3e/41419_2024_6958_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/fc17548efd52/41419_2024_6958_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/e9a011c80fac/41419_2024_6958_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/f7f5dda4b1c0/41419_2024_6958_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/bfb8a52c2293/41419_2024_6958_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/11372083/d76444e9aa40/41419_2024_6958_Fig10_HTML.jpg

相似文献

1
HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis.HIF1A-AS2 通过 miR-141-3p/FOXC1 轴促进结直肠癌细胞的代谢重编程和进展。
Cell Death Dis. 2024 Sep 3;15(9):645. doi: 10.1038/s41419-024-06958-2.
2
Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma.长链非编码 RNA HIF1A-AS2 通过海绵吸附 miR-33b-5p 来调节骨肉瘤中的 SIRT6 表达,从而促进细胞存活和迁移。
Biochem Cell Biol. 2020 Apr;98(2):284-292. doi: 10.1139/bcb-2019-0171. Epub 2019 Oct 18.
3
Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis.长链非编码 RNA COL4A2-AS1 通过 miR-20b-5p/缺氧诱导因子 1 亚基α轴促进结直肠癌细胞的增殖和糖酵解。
Bioengineered. 2021 Dec;12(1):6251-6263. doi: 10.1080/21655979.2021.1969833.
4
HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429/PD-L1 Axis.HIF1A-AS2 通过 miR-429/PD-L1 轴促进胃癌细胞的增殖和转移。
Dig Dis Sci. 2021 Dec;66(12):4314-4325. doi: 10.1007/s10620-020-06819-w. Epub 2021 Feb 8.
5
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.微小RNA-103a-3p通过河马/Yes相关蛋白1/缺氧诱导因子1α轴促进结直肠癌的肿瘤糖酵解。
J Exp Clin Cancer Res. 2020 Nov 20;39(1):250. doi: 10.1186/s13046-020-01705-9.
6
Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.反义长链非编码RNA HIF1A-AS2在胃癌中上调并与不良预后相关。
Dig Dis Sci. 2015 Jun;60(6):1655-62. doi: 10.1007/s10620-015-3524-0. Epub 2015 Feb 17.
7
Long noncoding RNA KCNMA1-AS2 regulates the function of colorectal cancer cells and sponges miR-1227-5p.长链非编码 RNA KCNMA1-AS2 调控结直肠癌细胞功能并作为 miR-1227-5p 的海绵体。
BMC Cancer. 2024 Jul 18;24(1):857. doi: 10.1186/s12885-024-12608-9.
8
LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.长链非编码 RNA HIF1A-AS2 通过调控 miR-129-5p 和 DNMT3A 正向影响结直肠癌的进展和 EMT 形成。
Biomed Pharmacother. 2018 Feb;98:433-439. doi: 10.1016/j.biopha.2017.12.058. Epub 2017 Dec 27.
9
Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.转录因子 SP1 诱导的 microRNA-146b-3p 通过调节 FAM107A 促进结直肠癌的进展和转移。
Life Sci. 2021 Jul 15;277:119398. doi: 10.1016/j.lfs.2021.119398. Epub 2021 Apr 5.
10
Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.长非编码 RNA HIF1A-As2 和 MYC 形成双重正反馈回路,促进 KRAS 驱动的非小细胞肺癌中的细胞增殖和转移。
Cell Death Differ. 2023 Jun;30(6):1533-1549. doi: 10.1038/s41418-023-01160-x. Epub 2023 Apr 11.

引用本文的文献

1
Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions.结直肠癌中的线粒体代谢重编程:耐药机制与未来临床干预措施
Cell Death Discov. 2025 Aug 9;11(1):375. doi: 10.1038/s41420-025-02670-y.
2
LncRNAs in hypoxic microenvironment; insight in their impact in cancer biology.缺氧微环境中的长链非编码RNA;对其在癌症生物学中影响的见解
Funct Integr Genomics. 2025 Jul 2;25(1):142. doi: 10.1007/s10142-025-01635-9.
3
Lactylation in tumor: mechanisms and therapeutic potentials.肿瘤中的乳酸化:机制与治疗潜力

本文引用的文献

1
Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer.癌症相关成纤维细胞衍生的外泌体DACT3-AS1缺失促进胃癌的恶性转化和铁死亡介导的奥沙利铂耐药。
Drug Resist Updat. 2023 May;68:100936. doi: 10.1016/j.drup.2023.100936. Epub 2023 Jan 31.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications.
Front Immunol. 2025 Jun 16;16:1609596. doi: 10.3389/fimmu.2025.1609596. eCollection 2025.
4
Research progress of colorectal cancer in genomic and transcriptomic at multi-level.结直肠癌在基因组和转录组多水平的研究进展
Front Genet. 2025 May 30;16:1533817. doi: 10.3389/fgene.2025.1533817. eCollection 2025.
5
Exploring the Link Between Noncoding RNAs and Glycolysis in Colorectal Cancer.探索非编码RNA与结直肠癌糖酵解之间的联系。
J Cell Mol Med. 2025 Feb;29(4):e70443. doi: 10.1111/jcmm.70443.
结直肠癌中的瓦博格效应:在肿瘤微环境中的新兴作用及其治疗意义。
J Hematol Oncol. 2022 Nov 1;15(1):160. doi: 10.1186/s13045-022-01358-5.
4
A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer.一个与缺氧相关的 lncRNA 特征与结直肠癌的生存和肿瘤微环境相关。
J Immunol Res. 2022 Jul 8;2022:9935705. doi: 10.1155/2022/9935705. eCollection 2022.
5
LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling.长链非编码 RNA 在肿瘤代谢重编程和免疫微环境重塑中的作用。
Cancer Lett. 2022 Sep 1;543:215798. doi: 10.1016/j.canlet.2022.215798. Epub 2022 Jun 20.
6
Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.外泌体来源的 FGD5-AS1 促进肿瘤相关巨噬细胞 M2 极化介导的胰腺癌细胞增殖和转移。
Cancer Lett. 2022 Nov 1;548:215751. doi: 10.1016/j.canlet.2022.215751. Epub 2022 Jun 16.
7
Construction of a prognostic glycolysis-related lncRNA signature for patients with colorectal cancer.构建用于结直肠癌患者的预后糖酵解相关 lncRNA 特征。
Cancer Med. 2023 Jan;12(1):930-948. doi: 10.1002/cam4.4851. Epub 2022 May 26.
8
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.肿瘤细胞和肿瘤相关巨噬细胞来源的外泌体非编码 RNA 在肿瘤微环境中的作用。
Mol Ther. 2022 Oct 5;30(10):3133-3154. doi: 10.1016/j.ymthe.2022.01.046. Epub 2022 Apr 9.
9
Colorectal liver metastasis: molecular mechanism and interventional therapy.结直肠癌肝转移:分子机制与介入治疗。
Signal Transduct Target Ther. 2022 Mar 4;7(1):70. doi: 10.1038/s41392-022-00922-2.
10
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.肿瘤相关成纤维细胞来源的外泌体长链非编码 RNA TUG1 通过调控 miR-524-5p/SIX1 轴促进肝癌细胞迁移、侵袭和糖酵解。
Cell Mol Biol Lett. 2022 Feb 22;27(1):17. doi: 10.1186/s11658-022-00309-9.